# FDA Inspection 1219023 - Aurobindo Pharma Limited - September 29, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-limited/710292e7-7ccc-4bcf-8241-84c108e63e16/
Source feed: FDA_Inspections

> FDA Inspection 1219023 for Aurobindo Pharma Limited on September 29, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219023
- Company Name: Aurobindo Pharma Limited
- Inspection Date: 2023-09-29
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1028769 - 2017-09-01](https://www.globalkeysolutions.net/api/records/fda_inspections/aurobindo-pharma-limited/554477ae-e726-479b-9a6f-b0f7c8879761/)
- [FDA Inspection 909414 - 2014-12-09](https://www.globalkeysolutions.net/api/records/fda_inspections/aurobindo-pharma-limited/f8dc3642-ade8-47df-ad05-98da46585c38/)
- [FDA Inspection 800619 - 2012-09-21](https://www.globalkeysolutions.net/api/records/fda_inspections/aurobindo-pharma-limited/08f430df-a1a5-4344-8230-c0e0e5a6f1c0/)
- [FDA Inspection 711843 - 2010-12-22](https://www.globalkeysolutions.net/api/records/fda_inspections/aurobindo-pharma-limited/aadd7f31-7246-4414-abdd-ca5789ca0014/)

Company: https://www.globalkeysolutions.net/companies/aurobindo-pharma-limited/526fd1b4-90b1-4e91-b9f5-a3eab997ed60

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c